The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Nagy, N.,
Bói, B.,
Papp, G.,
Fiák, E.,
Gáspár-Kiss, E.,
Perge, B.,
Farmasi, N.,
Tarr, T.:
Antiphospholipid Antibodies Are Major Risk Factors for Non-Thrombotic Cardiac Complications in Systemic Lupus Erythematosus.
Biomedicines. 12 (3), 1-15, (article identifier: 530), 2024.
Q1
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1
Medicine (miscellaneous)
2.
Perge, B.,
Papp, G.,
Bói, B.,
Nagy, N.,
Gáspár-Kiss, E.,
Tarr, T.:
Clinical Features and Survival Analysis of Lupus Nephritis among Patients with Systemic Lupus Erythematosus: a Three-Decade-Long Retrospective Cohort Study.
Biomedicines. 12 (9), 1-17, (article identifier: 2117), 2024.
Q1
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1
Medicine (miscellaneous)
2023
3.
Nagy, N.,
Papp, G.,
Gáspár-Kiss, E.,
Diószegi, Á.,
Tarr, T.:
Changes in Clinical Manifestations and Course of Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome over Three Decades.
Biomedicines. 11 (4), 1-10, (article identifier: 1218), 2023.
Q1
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1
Medicine (miscellaneous)
2022
4.
Szabó, K.,
Jámbor, I.,
Pázmándi, K. L.,
Nagy, N.,
Papp, G.,
Tarr, T.:
Altered Circulating Follicular T Helper Cell Subsets and Follicular T Regulatory Cells Are Indicators of a Derailed B Cell Response in Lupus, Which Could Be Modified by Targeting IL-21R.
Int. J. Mol. Sci. 23 (20), 1-20, (article identifier: 12209), 2022.
Tarr, T.,
Papp, G.,
Nagy, N.,
Cserép, E.,
Zeher, M.:
Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus.
Clin. Rheumatol. 36 (2), 327-333, 2017.
